Cleaning Validation · Health-Based Limits
PDE-Based MACO Calculation With Examples
A practical guide to converting a product-specific permitted daily exposure (PDE) into a maximum allowable carryover (MACO), then translating that limit into equipment-surface and sampling criteria.
Cleaning limits should protect patients from unintended exposure to residues carried over from a previous product. A PDE-based MACO calculation provides a health-based way to estimate the maximum mass of a previous active substance that may remain in shared equipment and be carried into the next product. The result depends on the previous product’s PDE and the next product’s minimum batch size and maximum daily dose.
The calculation is only one part of a cleaning validation strategy. Teams must also justify product sequencing, equipment surface allocation, sampling locations, analytical method capability, recovery treatment, and any more stringent site or regulatory criteria. This article explains the calculation with transparent units and examples so the result can be reviewed and translated into a defensible cleaning acceptance limit.
What Are PDE and MACO?
Permitted daily exposure (PDE)
A substance-specific daily exposure level derived from toxicological and pharmacological evidence, below which adverse effects are not expected under the defined assumptions. PDE is generally established by a qualified toxicologist or appropriately competent health-risk assessor.
Maximum allowable carryover (MACO)
The calculated maximum mass of a previous product’s residue that may be present in the next product’s batch under a defined product-to-product and equipment scenario.
PDE is a health-based exposure limit; MACO is a manufacturing carryover quantity. PDE is not itself a surface residue limit. It must be combined with the receiving product’s batch size and maximum daily dose to derive a permissible carryover mass. The European Medicines Agency’s HBEL guideline describes the toxicological basis for setting PDE values used in risk identification in shared facilities. citeturn139search0turn139search37
PDE-Based MACO Formula
The ratio of batch size to maximum daily dose represents the number of daily doses in the batch. Multiplying that amount by the PDE gives the theoretical carryover mass that would not cause the receiving patient’s daily exposure to exceed the PDE, assuming the residue is distributed uniformly through the next batch.
Define each input before calculating
- PDEprevious: the approved PDE for the previous active ingredient, selected for a relevant route and population. Use the controlled toxicological assessment and record its source, date, rationale, and applicable route.
- Minimum batch sizenext: the smallest routine or otherwise justified batch size of the next product manufactured on the shared equipment. Convert it to the same mass unit used in the dose.
- Maximum daily dosenext: the greatest daily amount of the receiving product’s active ingredient that a patient may take under the approved product information and intended use. Confirm product strength and dose basis.
- Product pair and equipment train: identify the previous product, next product, shared equipment, and all product-contact surfaces included in the carryover assessment.
Worked Example 1: Calculate the MACO
Assume the toxicological assessment assigns the previous active ingredient a PDE of 0.0002 mg/day (0.2 µg/day). The receiving product has a minimum batch size of 20 kg and a maximum daily dose of 500 mg/day.
Step 1: Convert the batch size
Step 2: Check the dose basis
The maximum daily dose is already expressed as milligrams of active ingredient per day. If the product dose is stated as tablets, capsules, millilitres, or a combination regimen, convert it to the total daily mass of active ingredient before using the formula.
Step 3: Substitute values
For this defined product pair and batch scenario, the calculated MACO is 8 mg of the previous active ingredient in the entire 20 kg next-product batch. This is a theoretical health-based carryover allowance, not a default cleaning target; a stricter criterion may govern.
Convert MACO Into Equipment-Surface Limits
To develop a surface-based acceptance criterion, divide the total MACO by the relevant shared product-contact surface area. This assumes a justified allocation of the total allowance across that equipment train. If the same equipment train has multiple items, document which surfaces are included and how the total carryover budget is distributed.
For the example above, assume the justified total shared product-contact area is 30,000 cm².
If a representative swab covers 25 cm², the corresponding swab residue amount is:
This is a mathematical conversion of the selected surface limit to the defined swab area. It does not mean every location can be treated as equally cleanable. Risk-based sampling should include difficult-to-clean locations, and the protocol should explain how sample results represent the equipment and the carryover budget.
Worked Example 2: Rinse-Sample Concentration
If the sampling strategy uses a rinse, a theoretical concentration limit can be estimated by dividing the allowable mass assigned to the sampled rinse by its defined volume. For illustration, if the entire 8 mg MACO were represented in an 8 L final rinse:
This conversion is valid only when the rinse volume, equipment coverage, sample representativeness, analyte solubility, and recovery are understood. A pooled rinse may dilute a localized residue or fail to recover residue from hard-to-wet surfaces. Do not automatically treat the whole-equipment MACO as a limit for every rinse sample; define the sampling basis and allocation in the protocol.
Example 3: Compare Product Pairs
MACO is specific to the direction of product change. Product A followed by Product B is a different calculation from Product A followed by Product C because the receiving products can have different minimum batch sizes and maximum daily doses.
| Receiving-product scenario | Minimum batch | Maximum daily dose | PDE of prior product | Calculated MACO |
|---|---|---|---|---|
| Product B | 20 kg | 500 mg/day | 0.0002 mg/day | 8 mg |
| Product C | 10 kg | 500 mg/day | 0.0002 mg/day | 4 mg |
| Product D | 20 kg | 100 mg/day | 0.0002 mg/day | 40 mg |
In this simplified set, the Product A-to-Product C transition produces the lowest MACO and is the most restrictive of these three health-based calculations. A complete program evaluates the actual product matrix, equipment train, route, and manufacturing conditions. The lowest number should not be selected mechanically if different equipment, cleaning processes, or toxicological assumptions apply; the grouping rationale must be documented.
How to Set the Final Cleaning Acceptance Limit
The PDE-based calculation informs a risk-based limit, but the final acceptance criteria should bring together the relevant health, process, equipment, analytical, and regulatory considerations.
- Confirm the health-based value. Verify that the PDE assessment is approved, product-specific, current, and applicable to the exposure route and population.
- Calculate each relevant product-to-product MACO. Use documented minimum batch sizes and maximum daily doses. Keep units visible through every conversion.
- Identify the shared equipment train. Include all product-contact surfaces and justify the surface-area basis. Review whether equipment is shared sequentially or used in a campaign arrangement.
- Translate the mass limit to sampling limits. Define the swab area or rinse volume, sample locations, rinse coverage, extraction procedure, and whether results are corrected for recovery.
- Assess method capability. The analytical procedure should be suitable for the residue, sampling matrix, and acceptance limit, with adequate specificity, recovery, detection, and quantitation capability.
- Apply other applicable criteria. Include visual cleanliness, detergent residues, microbial or endotoxin controls where relevant, and any lower applicable registered, pharmacopoeial, site, or market-specific limit.
- Approve and maintain the control strategy. Incorporate acceptance criteria, cleaning steps, sampling, deviations, change control, and ongoing monitoring in controlled procedures.
Current EU GMP Annex 15 identifies sampling locations and their rationale, acceptance criteria, and analytical method suitability as elements to define in cleaning validation protocols. The European Commission lists Annex 15 within EudraLex Volume 4. citeturn139search13turn139search40
Recovery Factor: Avoid Double Adjustment
Swab or rinse recovery describes how much residue the sampling and extraction procedure can recover from a surface or sample matrix. The protocol and analytical report should state whether reported results are raw or recovery-corrected.
- If sample results are recovery-corrected, compare the corrected result with the applicable residue limit.
- If results are not recovery-corrected, establish a justified measured-sample criterion that accounts for validated recovery, where appropriate.
- Do not both correct the measured result and reduce the acceptance limit for the same recovery factor; that would apply the adjustment twice.
Common PDE-Based MACO Calculation Errors
- Mixing micrograms and milligrams without converting them first.
- Using the previous product’s batch size instead of the receiving product’s minimum batch size.
- Using a usual dose rather than the maximum approved daily dose for the next product.
- Using a PDE that does not match the relevant route, patient group, or toxicological assessment.
- Assuming the calculated MACO is automatically the final cleaning limit without checking other criteria.
- Dividing the total MACO by only part of the equipment surface without a documented allocation rationale.
- Using a method with a quantitation limit above the required sample acceptance limit.
- Applying swab recovery correction twice or not documenting whether results were corrected.
- Using rinse sampling alone where a justified direct surface sample is feasible and needed to represent hard-to-clean locations.
- Reusing one product-pair MACO for every product and equipment transition without evaluating whether assumptions still hold.
Calculation and Documentation Checklist
- Approved PDE report and relevant exposure route are identified.
- Receiving product’s minimum batch size and maximum daily dose are verified from controlled sources.
- All units are converted consistently and arithmetic is independently checked.
- Product sequence and shared equipment train are clearly stated.
- Total product-contact surface area and any allocation are traceable.
- Swab area or rinse volume and sampling locations are justified.
- Recovery handling and reporting convention are defined.
- Analytical method sensitivity is appropriate for the resulting limit.
- Visual, cleaning-agent, and microbiological criteria are considered where relevant.
- Final limits, deviations, approvals, and periodic review triggers are recorded in controlled documents.
Maintain calculations and supporting data in accordance with cGMP and ALCOA+ recordkeeping principles. Define the approved method and responsibilities in the site SOP. For a broader framework, see Cleaning Validation in Pharmaceuticals. If a failure or recurring excursion occurs, manage the investigation through the applicable CAPA process.
Frequently Asked Questions
What is the formula for PDE-based MACO?
MACO (mg) = previous product PDE (mg/day) × next product minimum batch size (mg) ÷ next product maximum daily dose (mg/day).
What does the MACO result represent?
It represents the calculated maximum mass of the previous active substance that may be carried into the entire defined next-product batch under the calculation assumptions.
Why is the next product’s minimum batch size used?
A smaller receiving batch provides less product mass over which residue is diluted, so it generally produces a more restrictive allowable carryover for the same PDE and daily dose.
Why use the maximum daily dose of the next product?
The maximum daily dose represents the greatest amount of receiving product a patient may consume each day. It is used to estimate patient exposure to any residue distributed in that product.
Is PDE the same as MACO?
No. PDE is a health-based daily exposure value. MACO is a calculated mass of previous-product residue for a specific next product, batch size, and product transition.
Does a PDE-based MACO replace every other cleaning criterion?
No. The final acceptance strategy may also include more stringent applicable limits, visual cleanliness, cleaning-agent residues, microbial controls, and method or process considerations.
How do I convert MACO to a swab limit?
First divide MACO by the justified total shared contact surface area to obtain a surface residue limit. Multiply that limit by the defined swab area, then apply the approved recovery-reporting convention.
Should the swab result be corrected for recovery?
Follow the validated analytical method and approved protocol. Either compare recovery-corrected results with the stated limit or use a justified raw-result criterion; do not apply recovery correction twice.
Can the same MACO be used for every product pair?
Not automatically. Different receiving-product batch sizes and daily doses change the result, and PDEs, routes, equipment, and cleaning conditions may differ. Document product grouping and worst-case selection.
What if the analytical method cannot quantify below the calculated limit?
The method is not adequately sensitive for that acceptance criterion as written. Improve or select a suitable method, revise the sampling or cleaning strategy based on scientific justification, or implement other risk controls before approval.
Conclusion
A reliable PDE-based MACO calculation starts with a sound health-based exposure limit and uses the next product’s minimum batch size and maximum daily dose. Clear unit conversions then allow the total carryover mass to be translated into justified surface and sampling criteria. A calculation is defensible only when its assumptions, product sequence, equipment area, recovery approach, analytical sensitivity, and other applicable cleaning requirements are documented and controlled.
Educational information only. Cleaning validation limits must be approved through the site quality system and assessed against the current regulations and requirements applicable to the product, process, and market.
.webp)
